Connection

Francesca Colavita to Antibodies, Viral

This is a "connection" page, showing publications Francesca Colavita has written about Antibodies, Viral.
Connection Strength

0.121
  1. Measles Cases during Ebola Outbreak, West Africa, 2013-2106. Emerg Infect Dis. 2017 06; 23(6):1035-1037.
    View in: PubMed
    Score: 0.068
  2. Performance evaluation of Abbott ARCHITECT SARS-CoV-2 IgG immunoassay in comparison with indirect immunofluorescence and virus microneutralization test. J Clin Virol. 2020 08; 129:104539.
    View in: PubMed
    Score: 0.021
  3. Tetravalent SARS-CoV-2 Neutralizing Antibodies Show Enhanced Potency and Resistance to Escape Mutations. J Mol Biol. 2021 09 17; 433(19):167177.
    View in: PubMed
    Score: 0.006
  4. Immunogenicity of a new gorilla adenovirus vaccine candidate for COVID-19. Mol Ther. 2021 08 04; 29(8):2412-2423.
    View in: PubMed
    Score: 0.006
  5. SARS-CoV-2 Serum Neutralization Assay: A Traditional Tool for a Brand-New Virus. Viruses. 2021 04 10; 13(4).
    View in: PubMed
    Score: 0.006
  6. COVID-19 in people living with HIV: Clinical implications of dynamics of the immune response to SARS-CoV-2. J Med Virol. 2021 03; 93(3):1796-1804.
    View in: PubMed
    Score: 0.005
  7. Coronavirus disease (COVID-19) in a paucisymptomatic patient: epidemiological and clinical challenge in settings with limited community transmission, Italy, February 2020. Euro Surveill. 2020 03; 25(11).
    View in: PubMed
    Score: 0.005
  8. Occupational transmission of an Orthopoxvirus infection during an outbreak in a colony of Macaca tonkeana in Lazio Region, Italy, 2015. Zoonoses Public Health. 2018 08; 65(5):578-583.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.